Revolutionizing Alzheimer's disease and clinical trials through biomarkers - Wikidata - awgldk - TriplyDB

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

http://www.wikidata.org/entity/Q26744882

about

An amylin analog used as a challenge test for Alzheimer's disease.Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.Plasma tau in Alzheimer disease.Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.Repetitive head impact exposure and later-life plasma total tau in former National Football League players.Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid.Protective effects and mechanism of TPX2 on neurocyte apoptosis of rats in Alzheimer's disease model.Alzheimer's disease drug development pipeline: 2017.Factors influencing accuracy of cortical thickness in the diagnosis of Alzheimer's disease.Biomarkers: Delivering on the expectation of molecularly driven, quantitative health.Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.

P2860

Q33655621-00957D51-5FEC-420C-8393-E386FF28A6DC Q37307467-ABDD698E-E05C-4FBA-935A-8DCA2AEDCEBA Q37384690-E44855EE-E34D-4EF2-B4E6-8FAFD1762613 Q37530392-4072370C-5C26-4C4A-8250-6BD6F1E9FFAB Q37645272-F17CDA1D-C242-4BD7-9453-A419A78D0B1C Q39217840-76EF74E6-3BBC-4785-B3DE-C9E1696FA8CE Q42316688-5E6695C8-3429-43BE-83D9-F9ED30070753 Q42655757-9F0374F5-1FFC-40F5-B98C-31AFCCC5E255 Q47225592-FB80FBD0-E7C5-4260-B80E-0E1CC8C3C18A Q47377237-14559EDC-9943-44F6-A8E7-92F647872CB1 Q47560282-25CBFD98-B69B-41CC-9DCE-EDD4BCC7D8CB Q47587631-D9CB40DA-224E-4C51-9F60-13507DE46A4D Q47869899-7608F197-FD1A-4DE4-BCFE-55A0CEF4F688 Q48243501-D50463A0-8101-4F95-B94A-455FB36DD860 Q49135523-C79A8A11-AE21-4C18-A608-E529E448E9BF Q50532647-D2885F3D-A509-457C-B875-3C48811E94DA Q52721984-8431CDB5-0578-454D-B433-96599862682C Q55510342-BA2EDE24-FC71-40A9-B483-7FCF5BF9DEEB

P2860

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

http://www.wikidata.org/entity/Q26744882

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

@ast

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

@en

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

@nl

type

label

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

@ast

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

@en

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

@nl

prefLabel

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

@ast

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

@en

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

@nl

P1433

Q26744882-2CD11B7E-83A4-4AEB-B4AB-042306365DB4

P1476

Q26744882-C3309134-073D-41C1-A6C3-6646FA955EA4

P2093

Q26744882-1495B05B-3D10-4DB3-AFFB-C1DCF2C5C426

Q26744882-2515C872-B2E0-46ED-887F-B07CD71CB8D6

Q26744882-75FBA259-2517-4BBD-82C2-3C1F21B9A4C1

Q26744882-9332B312-0E4F-4983-8250-948D78306CF5

Q26744882-A9565B44-C944-4B03-BD56-4314F36C81A4

Q26744882-F4AB681B-9D03-427D-B83A-456FEF12D141

Q26744882-F5BB1EC1-A917-480A-A65C-4E5025763F4E

Q26744882-F8DE0A6B-0760-459B-AB78-9EB519301B6E

Q26744882-FEF91366-3B7C-4E85-B7C1-D2A9DC1C257D

P2860

Q26744882-0799FD52-892C-4BA2-AE54-B48E528ABE0B

Q26744882-0CBB3C7B-3C56-4259-A75C-BC244AC00AEB

Q26744882-0D534843-ACC4-4702-A38B-C8C19B7E48FF

Q26744882-13F6EC44-41F3-4C24-90D9-CDC6DD08001F

Q26744882-160AA901-5589-432C-9FDD-CF23FFF1453F

Q26744882-165498C2-B7F4-4986-8EB7-10BFF66F7260

Q26744882-180B0923-0508-4DA9-AC55-37AF5D753A5B

Q26744882-18D37E34-49B0-4EF8-A2E0-A93CE0694A17

Q26744882-1BA360E7-B6A1-4198-91B7-2ED48486D521

Q26744882-1D1D7828-A3AC-43B9-BDE8-54C0A18392E9

P304

Q26744882-BBB95F34-597D-4A5A-A54B-97F6CAB09931

P31

Q26744882-EF8748CC-3830-46F5-B3A1-0803FC0701D3

P3181

Q26744882-1E3AA8CF-E531-446E-AE20-67603BCB5A61

P356

Q26744882-26276F6C-1340-452C-B17D-E969D5FE67F6

P407

Q26744882-394256B9-1E19-409C-8904-CE4045AF9C28

P433

Q26744882-0ADADBE8-0E72-4B32-8C34-278414419B6F

P478

Q26744882-3C1C2334-4BB9-486D-9DFD-A4BADFC4BDD5

P50

Q26744882-0AF971FF-57B5-4FF2-9149-235CAB175C02

Q26744882-31617678-A4E9-4838-A0C3-505F58C1B909

Q26744882-B3100317-F35B-4B33-8022-9399262751D4

P577

Q26744882-08F91271-D33B-454D-B1C2-9EE92863B231

P5875

Q26744882-4B96D0C6-F8AA-4673-9FD7-6ED823C26C81

P698

Q26744882-5C1175EA-28BB-40A4-90DF-A983302792A8

P921

Q26744882-6320DE4B-387E-43BB-9EC2-9E25F9FE6947

Q26744882-651FA5F8-2924-48FC-898A-599F1A444EE9

P932

Q26744882-37B82D21-7134-41B9-B1E8-8C790803A146

P3181

P356

J.DADM.2015.09.001

P1433

Alzheimer's & dementia (Amsterdam, Netherlands)

P1476

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

@en

P2093

Enchi Liu

http://www.w3.org/2001/XMLSchema#string

Hugh Salter

http://www.w3.org/2001/XMLSchema#string

Lisa J Bain

http://www.w3.org/2001/XMLSchema#string

Michael D Devous

http://www.w3.org/2001/XMLSchema#string

Pedro Pesini

http://www.w3.org/2001/XMLSchema#string

Reisa S Sperling

http://www.w3.org/2001/XMLSchema#string

Robert A Dean

http://www.w3.org/2001/XMLSchema#string

Tania Nikolcheva

http://www.w3.org/2001/XMLSchema#string

William Z Potter

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception

Worldwide Alzheimer's disease neuroimaging initiative

Alliance for aging research AD biomarkers work group: structural MRI.

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

P304

412-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4043701

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.DADM.2015.09.001

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Randall J. Bateman

Maria C Carrillo

Niklas Mattsson

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283156021

http://www.w3.org/2001/XMLSchema#string

P698

27239522

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4879481

http://www.w3.org/2001/XMLSchema#string